Shanghai Xuhui Hospital
Shanghai Xuhui Hospital
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Site, liver cancer, liver disorder, neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2026-05-20 | NCT07587034 |